Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer-Reference-Cited by-同舟云学术

Docetaxel, bevacizumab, and androgen deprivation therapy for biochemical disease recurrence after definitive local therapy for prostate cancer

Published:2015-04-22 Issue:15 Volume:121 Page:2603-2611
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

McKay Rana R.¹,Gray Kathryn P.¹,Hayes Julia H.¹,Bubley Glenn J.²,Rosenberg Jonathan E.³,Hussain Arif⁴,Kantoff Philip W.¹,Taplin Mary-Ellen¹

Affiliation:

1. Lank Center for Genitourinary Oncology; Dana-Farber Cancer Institute; Boston Massachusetts

2. Genitourinary Medical Oncology; Beth Israel Deaconess Medical Center; Boston Massachusetts

3. Genitourinary Oncology Service; Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center; New York New York

4. Medical Oncology/Hematology Program, Greenebaum Cancer Center; Baltimore Maryland

Funder

Genetech

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.29398/fullpdf

Reference16 articles.

1. Cancer statistics, 2014;Siegel;CA Cancer J Clin,2014

2. Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy;Novara;Eur Urol,2012

3. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

4. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up;Antonarakis;BJU Int,2012

5. Management of patients with biochemical recurrence after local therapy for prostate cancer;Paller;Hematol Oncol Clin North Am,2013

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should androgen deprivation therapy and other systemic treatments be used in men with prostate cancer and a rising PSA post-local treatments?;Therapeutic Advances in Medical Oncology;2021-01

2. Leptin Promotes Prostate Cancer Proliferation and Migration by Stimulating STAT3 Pathway;Nutrition and Cancer;2020-07-22

3. A review of salvage treatment options for disease progression after radiation therapy for localized prostate cancer;Urologic Oncology: Seminars and Original Investigations;2019-09

4. Phase 2 Randomized Study of Radiation Therapy and 3-Year Androgen Deprivation With or Without Concurrent Weekly Docetaxel in High-Risk Localized Prostate Cancer Patients;International Journal of Radiation Oncology*Biology*Physics;2019-02

5. Issues and promises of bevacizumab in prostate cancer treatment;Expert Opinion on Biological Therapy;2018-05-30